1982
DOI: 10.1093/clinids/4.2.614
|View full text |Cite
|
Sign up to set email alerts
|

A Controlled Study of Trimethoprim-Sulfamethoxazole Prophylaxis of Urinary Tract Infection in Renal Transplant Recipients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
47
2

Year Published

1991
1991
2014
2014

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 117 publications
(49 citation statements)
references
References 20 publications
0
47
2
Order By: Relevance
“…This intervention is predicated on the finding in at least one study that early UTI may be associated with diminished allograft function, at least transiently, and that trimethoprim-sulfamethoxazole prophylaxis reduces the risk for UTI threefold, without resulting in significant colonization by trimethoprim-sulfamethoxazole-resistant gram-negative bacilli (77,78). Whether patients who are unable to receive trimethoprim-sulfamethoxazole should be given alternative prophylaxis is not known, but that option could be considered (5).…”
Section: Urinary Tract Infectionmentioning
confidence: 99%
“…This intervention is predicated on the finding in at least one study that early UTI may be associated with diminished allograft function, at least transiently, and that trimethoprim-sulfamethoxazole prophylaxis reduces the risk for UTI threefold, without resulting in significant colonization by trimethoprim-sulfamethoxazole-resistant gram-negative bacilli (77,78). Whether patients who are unable to receive trimethoprim-sulfamethoxazole should be given alternative prophylaxis is not known, but that option could be considered (5).…”
Section: Urinary Tract Infectionmentioning
confidence: 99%
“…(44,45). (21,49 (49,50), and led to recommendations for use of prophylactic antibiotics (TMP-SMX) for 6 months-1 year posttransplant (45). As uropathogenic bacteria have become more TMP-SMX resistant (40,41) …”
Section: Risk Factorsmentioning
confidence: 99%
“…Trimethoprim/sulfamethoxazole (TMP/SMX), traditionally used for prophylaxis against Pneumocystis jiroveci pneumonia, has proven efficacy in reducing the incidence of UTIs, as well as bacteremias after transplantation [36,37], although resisitance to common urinary tract pathogens is increasingly common in more recent years [16,38]. TMP/SMX is also effective in preventing infections by L monocytogenes, Nocardia species, and Toxoplasmosis gondii, leading to recommendations for its use in all patients without contraindication to its use [2].…”
Section: Prophylaxis Of Bacterial Infectionmentioning
confidence: 99%